首页> 美国卫生研究院文献>ACS Medicinal Chemistry Letters >Macrocyclic Hedgehog PathwayInhibitors: Optimizationof Cellular Activity and Mode of Action Studies
【2h】

Macrocyclic Hedgehog PathwayInhibitors: Optimizationof Cellular Activity and Mode of Action Studies

机译:大环刺猬通路抑制剂:优化活动和作用方式研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Macrocyclic Hedgehog (Hh) pathway inhibitors have been discovered with improved potency and maximal inhibition relative to the previously reported macrocycle robotnikinin. Analogues were prepared using a modular and efficient build-couple-pair (BCP) approach, with a ring-closing metathesis step to form the macrocyclic ring. Varying the position of the macrocycle nitrogen and oxygen atoms provided inhibitors with improved activity in cellular assays; the most potent analogue was >29 (BRD-6851), with an IC50 of 0.4 μM against C3H10T1/2 cells undergoing Hh-induced activation, as measured by Gli1 transcription and alkaline phosphatase induction. Studies with Patched knockout (Ptch–/–) cells and competition studies with the Smoothened (Smo) agonists SAG and purmorphamine demonstrate that in contrast to robotnikinin, select analogues are Smo antagonists.
机译:相对于以前报道的大环机器人尼基宁,已发现具有增强的效力和最大抑制作用的大环刺猬(Hh)途径抑制剂。使用模块化且有效的构建偶联对(BCP)方法制备类似物,并采用闭环复分解步骤形成大环。改变大环氮原子和氧原子的位置可以为抑制剂提供更好的细胞分析活性。最有效的类似物是> 29 (BRD-6851),通过Gli1转录和碱性磷酸酶诱导,对经历Hh诱导活化的C3H10T1 / 2细胞的IC50为0.4μM。用修补基因敲除(Ptch – / – )细胞进行的研究以及使用Smoothened(Smo)激动剂SAG和purmorphamine进行的竞争研究表明,与robotnikinin相比,某些类似物是Smo拮抗剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号